Professor of Medicine, Brown University

Infectious Disease

Timothy Flanigan works in the field of Infectious Disease. He graduated from Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18 in research and 49 in primary care medicine He over the years received 3 awards: "America's Top Doctors", "Fellow (FACP)" and "Top MD". Timothy Flanigan is also published. He has 82 publications published. The lastest publication: "Delayed entry to care by men with HIV infection in Kumasi, Ghana.'

Publications

---

• Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical T...
• Tick-borne illness in Rhode Island - how big a problem is it?
• Preventing HIV Transmission Among Partners of HIV-Positive Male Sex Workers in Mexico City: A Modeling Study.
• Geographic variability in HIV and injection drug use in Ukraine: Implications for integration and expansion of drug treatment and HIV care.
• Love, lust and the emotional context of multiple and concurrent sexual partnerships among young Swazi adults.
• Epidemiology of hepatitis C virus in pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings.
• Missed Opportunities for HIV Screening in Pharmacies and Retail Clinics.
• The Feasibility of Implementing the HIV Seek, Test, and Treat Strategy in Jails.
• Care at the Crossroads: Navigating the HIV, HCV, and Substance Abuse Syndemic.
• HCV Testing and Drug Use in North America; Is There More Than Meets the Eye?
• Contribution of Substance Use Disorders on HIV Treatment Outcomes and Antiretroviral Medication Adherence Among HIV-Infected Persons Entering Jail.
• Changes in HIV-1 Subtypes B and C Genital Tract RNA in Women and Men After Initiation of Antiretroviral Therapy.
• HIV testing practices among New England college health centers.
• What's God got to do with it? Engaging African-American faith-based institutions in HIV prevention.
• HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care.
• New HIV infections at Southern New England academic institutions: Implications for prevention.
• African American patient experiences with a rapid HIV testing program in an urban public clinic.
• Keeping the Faith: African American Faith Leaders' Perspectives and Recommendations for Reducing Racial Disparities in HIV/AIDS Infection.
• Adherence to HIV Treatment and Care Among Previously Homeless Jail Detainees.
• Is expanded HIV treatment preventing new infections?: Impact of antiretroviral therapy on sexual risk behaviors in the developing world.
• The intertwined epidemics of HIV infection, incarceration, and substance abuse: a call to action.
• Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART after First-Line Failure among South Indian HIV-Infected Patients.
• Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen.
• HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City.
• Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention.
• Follow-up care among HIV-infected pregnant women in Mississippi.
• HIV risk behavior before and after HIV counseling and testing in jail: a pilot study.
• Changes in demographics and risk factors among persons living with HIV in an academic medical center from 2003-2007.
• HIV among marginalized populations in Rhode Island.
• Lessons learned from a training collaboration between an Ivy League institution and a historically Black university.
• Small reservoirs: jail screening for gonorrhea and Chlamydia in low prevalence areas.
• HIV and infectious disease care in jails and prisons: breaking down the walls with the help of academic medicine.
• Routine HIV testing in jails is critical for the early diagnosis of HIV infection in men.
• Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge.
• Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients.
• Highly active antiretroviral therapy (HAART)--plus: next steps to enhance HAART in resource-limited areas?
• Initial outcomes of an emergency department rapid HIV testing program in western Kenya.
• Adverse effects of highly active antiretroviral therapy in developing countries.
• HIV counseling and testing among injection drug users needs to continue.
• Routine HIV testing in US prisons.
• Feasibility and acceptability of rapid HIV testing in jail.
• The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult.
• Public health principles for the HIV epidemic.
• Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India.
• Screening for HIV.
• Antiretroviral rounds. A communication conundrum.
• The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India.
• Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy.
• The use of community-based modified directly observed therapy for the treatment of HIV-infected persons.
• Lessons learned from use of highly active antiretroviral therapy in Africa.
• Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection.
• It is time to implement routine, not risk-based, HIV testing.
• The extraordinary hope of antiretroviral therapy in South Africa (even for patients with tuberculosis or kaposi sarcoma!).
• A diagnostic dilemma in a patient receiving antiretroviral and antituberculosis therapy.
• Racial/ethnic attitudes towards HIV testing in the primary care setting.
• Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus.
• Apathy is associated with volume of the nucleus accumbens in patients infected with HIV.
• Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India.
• Community-based interventions for marginalized populations.
• Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients.
• Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings.
• Directly observed therapy for HIV/tuberculosis co-infection.
• Confronting the clinical uncertainty regarding syphilis.
• Routine, not risk-based, human immunodeficiency virus testing is the way to go.
• A review of the case for hepatitis B vaccination of high-risk adults.
• Point of view: the rapid spread of HIV among minority communities in the United States: a call to action.
• The impact of apathy and depression on quality of life in patients infected with HIV.
• Directly observed therapy (DOT) for individuals with HIV: successes and challenges.
• Natural history of human immunodeficiency virus disease in southern India.
• Lipid changes in patients initiating efavirenz- and indinavir-based antiretroviral regimens.
• Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries.
• Acceptability of sexually transmitted infection screening among women in short-term substance abuse treatment.
• Monitoring HIV treatment in the developing world.
• Routine HIV testing among inpatients.
• The importance of routine HIV testing in the incarcerated population: the Rhode Island experience.
• Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1.
• Human immunodeficiency virus in correctional facilities: a review.
• Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
• Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175).
• Outcomes among HIV-1 Infected Individuals First Starting Antiretroviral Therapy with Concurrent Active TB or Other AIDS-Defining Disease.
• Delayed entry to care by men with HIV infection in Kumasi, Ghana.

Schools

---

• Weill Cornell Medical College

• Hospital Of The University Of Pennsylvania

• Case Western Reserve University

Doctors Specialties

---

• Infectious Disease Medicine
• Infectious Disease

Accepted Insurances

---

Awards

---

• America's Top Doctors
• Fellow (FACP)
• Top MD

Education

---

• University of Pennsylvania Health System
• Weill Cornell Medical College of Cornell University

Hospital

---

• Rhode Island Hospital

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Amanda J. Noska, MD This Doctor is OpenDoctor Recommended.
	Sajeev Handa, MB This Doctor is OpenDoctor Recommended.
	Dr. William Hahn, MD
	Dr. Davinderpal Singh, MD This Doctor is OpenDoctor Recommended.
	Dr. Tanya Ali, MD This Doctor is OpenDoctor Recommended.
	Dr. Vinod Thomas, MD This Doctor is OpenDoctor Recommended.
	Dr. Gail Skowron, MD This Doctor is OpenDoctor Recommended.
	Dr. Louis B. Rice, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jonathan Dworkin, MD This Doctor is OpenDoctor Recommended.
	Dr. Michelle A. Lally, MD This Doctor is OpenDoctor Recommended.
	Dr. John R. Lonks, MD This Doctor is OpenDoctor Recommended.
	Dr. Jerome M. Larkin, MD This Doctor is OpenDoctor Recommended.
	Dr. Cheston B. Cunha, MD This Doctor is OpenDoctor Recommended.
	Dr. Erna M. Kojic, MD This Doctor is OpenDoctor Recommended.
	Dr. Curt G. Beckwith, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog